Tiny Gems

Thursday Nov 10, 2022 - 3:25 pm

InvestorNewsBreaks – Mullen Automotive Inc.’s (NASDAQ: MULN) Bollinger Motors Selects Our Next Energy as Battery Supplier for Electric Commercial Trucks

Mullen Automotive’s (NASDAQ: MULN) majority owned company, Bollinger Motors, today announced that Our Next Energy will be supplying modular, linkable Aries battery packs to power its all-electric commercial platforms and chassis cabs. Bollinger’s all-electric Class 4 through Class 6 chassis cabs are designed to meet the needs of commercial customers in a segment that often requires large payloads, sufficient range, durability, and longevity. “ONE battery…

Thursday Nov 10, 2022 - 1:15 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces First-Ever Study Exploring Therapeutic Use of DehydraTECH-CBD in Dementia

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, is starting a new study program — DEM-A22-1 — on Nov. 15, 2022. The study, a first for Lexaria, will evaluate whether LEXX’s DehydraTECH-processed cannabidiol (“CBD”) may have potential for therapeutic treatment for dementia. According to the announcement, Lexaria has previously shown the efficacy of DehydraTECH-CBD in studies focused on human hypertension; the studies showed…

Thursday Nov 10, 2022 - 12:19 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Reports Majority of Franchise Global Health (TSX.V: FGH) Shareholders Approve Acquisition

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, is one step closer to completing its previously announced acquisition of Franchise Global Health (TSX.V: FGH). FLGC announced that holders of more than 73% of the outstanding shares of FGH have agreed to vote their shares in favor of Flora’s acquisition of FGH; the voting will take place during…

Thursday Nov 10, 2022 - 12:13 pm

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Progress on Clinical Path for CYB004

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced progress on its CYB004-E Phase 1 trial evaluating N,N-dimethyltryptamine (“DMT”). According to the update, dosing has been completed for four out of five participant cohorts, and The Safety Review Committee has confirmed no clinically significant safety or tolerability issues. The trial was acquired from Entheon Biomedical Corp. in…

Thursday Nov 10, 2022 - 11:48 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event

InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific…

Thursday Nov 10, 2022 - 10:23 am

InvestorNewsBreaks – Tingo Inc. (TMNA) Announces Launch of Operations in Ghana, Entry into Landmark Trade Deal with the Kingdom of Ashanti

Tingo (OTC: TMNA) today announced that Tingo Mobile PLC (“Tingo Mobile”) has opened a head office in Accra, Ghana, and has launched nationwide operations. According to the update, Tingo Mobile’s business in Ghana is held through a wholly owned subsidiary, Tingo Mobile Ghana Ltd (“Tingo Ghana”). To coincide with the launch, Tingo Ghana has agreed on a landmark trade deal with the Kingdom of Ashanti,…

Wednesday Nov 09, 2022 - 2:14 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Deploys 25 More ASRs, K1 Blue Light Towers Across the US

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots, announced that it has activated more machines across the country. According to the announcement, the deployed equipment consists of ASRs and one of Knightscope’s newest products, the K1 Blue Light Tower. Deployment locations include another California resort and casino, a privately owned global real estate investment, a development and management firm with 634 properties, a…

Wednesday Nov 09, 2022 - 1:46 pm

InvestorNewsBreaks – Tingo Inc. (TMNA) Announces Filing of Definitive Information Statement to Merge with MICT

Tingo (OTC: TMNA), a leading agri-fintech business in Africa, has filed a Definitive Information Statement with the U.S. Securities and Exchange Commission (“SEC”). The statement outlines the completion of the merger between Tingo Mobile PLC, a wholly owned Tingo subsidiary, with MICT Inc., a NASDAQ-traded financial technology company; the merger should be complete by the end of this month. Once the merger is finalized, MICT will…

Wednesday Nov 09, 2022 - 1:26 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Inks Distribution Deal for Expansion into Ireland, UK

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has signed a distribution agreement with Newgate Motor Group, one of Ireland’s best-known dealerships. The agreement calls for Newgate to serve as the marketing, sales, distribution and servicing agent for the Mullen I-GO in Ireland and the United Kingdom. As part of the agreement, Newgate will purchase initial units of I-GO for use in vehicle…

Tuesday Nov 08, 2022 - 12:17 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences 1st-Ever Study Evaluating DehydraTECH-CBD’s Effect on Diabetes

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that study program DIAB-A22-1 is expected to begin on schedule today. According to the announcement, this is Lexaria’s first-ever study to investigate whether its patented DehydraTECH-processed cannabidiol (“CBD”) may potentially have therapeutic utility against diabetes. The company has evidenced the safety and efficacy of DehydraTECH-CBD in human hypertension studies. Strong connections…

Monday Nov 07, 2022 - 1:53 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Targeted ‘Finish Line Is Within Sight’ as It Pursues Potential GBM Treatment

CNS Pharmaceuticals (NASDAQ: CNSP) has been developing drug candidates for treating primary and metastatic brain and central nervous system cancer. “Berubicin, the company’s lead drug candidate, is a novel anthracycline in an ongoing international trail in glioblastoma (“GBM”) treatment. The interim analysis data from this potentially pivotal trial is expected in mid-2023… Berubicin was the first [anthracycline] to provide scientific data which appears to demonstrate…

Monday Nov 07, 2022 - 11:55 am

InvestorNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Announces Q3-2022 Results, Continued Strengthening of Leading Position in Uranium, Rare Earth Elements

Energy Fuels (NYSE American: UUUU) (TSX: EFR) announced its financial results for the quarter ended Sept. 30, 2022. Among the highlights, the company reported a robust balance sheet with $122.3 million of working capital as of Sept. 30, 2022, including $77.1 million of cash and cash equivalents, $11.6 million of marketable securities, $27.3 million of inventory, and no short-term (or long-term) debt. The company’s product…

Monday Nov 07, 2022 - 11:32 am

InvestorNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Partner with Leading Entities to Complete Project Resulting in Enhanced Road Safety

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator of high-performance lidar solutions, has joined with two other leading companies to complete a proof-of-concept project confirming that an integrated system has the ability to warn drivers of unseen hazards ahead. The other two companies involved in the project, dubbed Periscope, are ALP.Lab GmbH, an Austria-based technology provider of autonomous vehicle testing solutions, and TE Connectivity, a…

Monday Nov 07, 2022 - 11:06 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Featured in Cleantech and Climate Change Podcast

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, was featured in a new edition of the Cleantech and Climate Change Podcast issued by Investorideas.com, a global news source and leading investor resource covering clean technology and renewable energy stocks issues. Mullen’s Founder, Chairman and CEO David Michery joined the podcast to discuss recent news and milestones and lay out Mullen’s future plans for…

Friday Nov 04, 2022 - 2:01 pm

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Increasing Access to Safe, Legal CBD and THC to Global Consumers

Flora Growth Corp. (NASDAQ: FLGC) is a cannabis cultivator, brand manufacturer and global distributor. “The Canadian company with a productive base of operations in Colombia’s fertile greenbelt is licensed to cultivate cannabis on a 100-hectare (about 247-acre) farming facility and then deliver its product to its GMP-certified processing facility in the nation’s capital, where beauty, phytotherapeutic and nutraceutical products are prepared for market…. Flora’s brand…

Friday Nov 04, 2022 - 1:00 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Announces Full Acquisition of Interest in RKings Competitions

Golden Matrix Group (NASDAQ: GMGI), a developer and licensor of gaming platforms, systems and gaming content, has acquired the remaining 20% interest in RKings Competitions; the company now owns a total of 165,444 restricted shares of GMGI’s common stock payable to the two former owners of RKings. Company officials announced the transaction, which makes RKings a wholly owned entity of Golden Matrix, one which the company…

Thursday Nov 03, 2022 - 10:13 am

InvestorNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Announces Participation Schedule for Upcoming Investor Events

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(R), today announced its participation in upcoming investor events. The company’s Chief Executive Officer Doug Drysdale will present and host investor meetings at the Jefferies London Healthcare Conference taking place on Nov. 15-17, 2022. Drysdale’s presentation is slated to begin at 8:00 a.m. GMT on Nov. 15. Drysdale will also participate…

Thursday Nov 03, 2022 - 10:00 am

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Distinctive in Highly Competitive Online Gambling Space

Golden Matrix (NASDAQ: GMGI), a developer and licensor of online gaming platforms, systems and gaming content, white labels its industry-leading GM-AG System that can be custom-built from 10,000+ game options for its roughly 650 clients serving about 6.8 million end users. “The online gambling space is highly competitive, leading to most of the world’s biggest operators burning through tons of cash for marketing in a…

Wednesday Nov 02, 2022 - 2:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Eyes Steady Growth, Traction in Distinctive Solutions

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) has grown its operations with numerous improvements to its cloud-based marketplace that simplifies the once-complex process of international over-the-road (“OTR”) cross-border shipping. In addition, Fr8Tech is constantly exploring new ways to create value for its clients, streamline the region’s cross-border shipping process, and carry that over into respective domestic markets. Its efforts to date have yielded six distinctive solutions in…

Tuesday Nov 01, 2022 - 1:07 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Secures IRB Approval for Human Clinical Nicotine Study

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced its receipt of independent review board (“IRB”) approval for human clinical nicotine study NIC-H22-1, and that human dosing will begin soon. The 36-person human pharmacokinetic (“pk”) randomized, double blinded, cross-over study will be conducted in current cigarette smokers, wherein each person will visit the laboratory to be dosed three times over…

Tuesday Nov 01, 2022 - 12:46 pm

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Exec to Present at Neuropsychiatric & Psychedelics Drug Development Summit

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), will be participating in the 5th annual Neuropsychiatric & Psychedelics Drug Development Summit. The summit runs through Nov. 2, 2022, and is being held in Boston. Cybin director of neuropharmacology Amy Reichelt, PhD, will present during the event; her presentation, titled “CYB004 — Modifications to DMT to Enhance its Therapeutic Potential,” includes…

Monday Oct 31, 2022 - 1:53 pm

InvestorNewsBreaks – CNS Pharmaceuticals Inc.’s (NASDAQ: CNSP) Berubicin Shows Superior Performance to Other Anthracyclines, Standards of Care for GBM

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical innovator staking out its own position within the competitive field of research, having already progressed to human trials evaluating its novel glioblastoma multiforme (“GBM”) solution, known as Berubicin (or WP744). “Berubicin is a patented doxorubicin (‘Dox’) analog – an anthracycline chemotherapy agent novel in its ability to cross the blood-brain barrier to target tumors directly. Tested against Dox…

Monday Oct 31, 2022 - 1:38 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Secures LOI for up to $100M to Help Fund next Stage of Growth

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and pioneer within high-performance lidar solutions, has rapidly emerged as a leader amongst its peers – deploying its unique capabilities across a host of different environments, ranging from traffic systems in Cape Town, South Africa, to airport terminal monitoring in the U.S. “Cepton’s long-term automotive Tier 1 partner, Koito Manufacturing Co. Ltd., recently revealed that it had provided…

Monday Oct 31, 2022 - 9:40 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Shares Responses from Participants of Its Strikingly Different FIVE EV Crossover Tour

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle ("EV") manufacturer, is seeing an overwhelmingly positive response to its Strikingly Different FIVE EV Crossover tour. Tour participants, including potential buyers and Mullen investors, who reserve a spot on the tour are enjoying the opportunity to ride the Mullen EV Crossover and personally interact with Mullen’s updated infotainment system, which features PERSONA, Mullen’s proprietary Personal Vehicle Assistant…

Friday Oct 28, 2022 - 1:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Announces Multi-Year Commitment with Kimberly Clark de Mexico, S.A.B. de C.V.

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company developing solutions to optimize and automate the supply chain process as well as providing a platform for B2B cross-border shipping in the United States-Mexico-Canada (“USMC”) region, has announced its receipt of a two-year commitment from Kimberly Clark de Mexico, S.A.B. de C.V. to expand its fixed-fleet product. Earlier this year, the company announced the launch of its…

Friday Oct 28, 2022 - 12:17 pm

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Reports Higher-than-Expected Preorders for Mullen FIVE Electric-SUV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is accepting preorders for its Mullen FIVE vehicle, and the company’s Strikingly Different EV Crossover Tour has had a significant impact on those orders. The tour kicked off earlier this week, and preorders for the new SUV crossover quadrupled in the period leading up to and during the tour’s first stop in Pasadena, California. Those…

Thursday Oct 27, 2022 - 1:45 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Expands Relationship with American Fortune 500 Glass Container Manufacturer

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”), a technology company offering its custom-developed Fr8App platform, which is powered by AI and machine learning and offers a real-time portal for B2B cross-border shipping and domestic shipping within the United States-Mexico-Canada (“NAFTA”) region, today announced the expansion of its commercial relationship with a leading glass container manufacturing company based in Ohio. “Since early 2021, the Fr8App platform has supported…

Thursday Oct 27, 2022 - 1:12 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Reports Successful Results of Human Clinical Hypertension Study

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study, HYPER-H21-4, may be the first-ever study to indicate a sustained drop in blood pressure (“BP”) in normally active hypertensive patients following multiple weeks of oral cannabidiol ("CBD") therapy. The study is evaluating Lexaria's patented DehydraTECH(TM)-CBD capsule formulation. LEXX reported that study results showed exceptional safety and tolerability and…

Thursday Oct 27, 2022 - 11:54 am

InvestorNewsBreaks — Cepton Technologies Inc. (NASDAQ: CPTN) Enters $100M Agreement with Koito Manufacturing

Cepton Technologies (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance lidar solutions, has signed a binding investment agreement with its long-term automotive tier 1 partner and current shareholder, Koito Manufacturing Co. Ltd. The company anticipates using the funds — $100 million — for its next stage of growth as it grows its lidar solutions and looks toward mass deployment. The agreement has been approved by…

Thursday Oct 27, 2022 - 11:18 am

InvestorNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) EMBARK Program Graduates Class of Facilitators

Cybin (NEO: CYBN) (NYSE American: CYBN), a biopharmaceutical company focused on progressing Psychedelics to Therapeutics(TM), and its EMBARK Psychedelic-Assisted Psychotherapy Training Program have announced the graduation of highly skilled facilitators who are now prepared to handle a range of experiences that participants of psychedelic-assisted psychotherapy may undergo. The training program includes foundational training enabling participants to learn the skills necessary to provide ethical care for and…

Thursday Oct 27, 2022 - 10:35 am

InvestorNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Featured in Latest Cleantech and Climate Change Podcast Report on EV Stocks

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, is spotlighted in the new edition of the Cleantech and Climate Change Podcast, issued by Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks. The episode focuses on the electric vehicle space and talks about the growth story of the EV market. During the episode, Mullen’s latest announcement that…

Wednesday Oct 26, 2022 - 2:38 pm

InvestorNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Stands Distinct from Others in Lidar Sector

Cepton (NASDAQ: CPTN), a world-leading lidar provider, remains committed to making a potentially game-changing technology available in everyday cars, not just luxury vehicles. “The company expects lidar to benefit more consumers as the technology gets rolled out to all cars, making autonomous driving safer for all. Cepton’s partnership with world-leading automotive tier 1 supplier, Koito, a Tokyo-based manufacturer with century-long operations, marks a significant milestone…

Wednesday Oct 26, 2022 - 1:54 pm

InvestorNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) Robot Show Takes the Spotlight in Houston, Texas

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”), has announced that its Robot Roadshow will land at EastGroup Properties, 3955 World Houston Pkwy, in Houston, Texas, on Oct. 27, 2022. The Robot Roadshow is an engaging experiential event designed to grab attention, forge direct connections with potential clients, and strike up conversations in a compelling fashion. The announcement reads, “The Houston Roadshow…

Wednesday Oct 26, 2022 - 11:55 am

InvestorNewsBreaks – QSAM Biosciences Inc. (QSAM) Announces Approval of Second Clinical Trial Site for Phase 1 Study

QSAM Biosciences (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP, or CycloSam(R), for the treatment of bone cancer and related diseases, has added Rutgers Cancer Institute of New Jersey (“RCINJ”) as a clinical trial site for its phase 1 CycloSam study. RCINJ has been approved to begin enrolling patients into the study, which will evaluate the effectiveness of CycloSam in treating patients with bone…

Wednesday Oct 26, 2022 - 10:45 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces Official Start of the Demonstrator US Tour for Its FIVE EV Crossover

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced the beginning of the Mullen FIVE Strikingly Different EV Crossover Tour, which will commence on Oct. 27 in Pasadena, California. Due to overwhelming interest, the tour has been expanded to add new dates of Nov. 1 and 2 at Angel Stadium in Anaheim, California. “When we announced the Pasadena location, we received an…

Wednesday Oct 26, 2022 - 10:05 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week

InMed Pharmaceuticals (NASDAQ: INM), a leader in the research, development and manufacturing of rare cannabinoids, today announced that it is supporting initiatives to raise awareness of epidermolysis bullosa, a group of rare genetic connective tissue disorders. Epidermolysis Bullosa Global Awareness Week is Oct. 25-31, 2022. “In severe cases of epidermolysis bullosa, or EB, the very fragile skin tears easily and forms painful blisters and open…

Tuesday Oct 25, 2022 - 12:45 pm

InvestorNewsBreaks – Freight Technologies Inc.’s (NASDAQ: FRGT) Solutions Designed to Improve Customers’ Efficiency, Profitability, Logistic Experiences

Freight Technologies (NASDAQ: FRGT), a company that develops solutions aimed at optimizing and automating the supply chain process, aims to revolutionize logistics operations for brokers, carriers and shippers by leveraging technology infrastructure to improve experiences and efficiency. “The infrastructure combines everything in a single control center, optimizing logistics, making fleets more efficient and reducing transportation costs,” reads a recent article. “Through its wholly owned subsidiary…

Monday Oct 24, 2022 - 10:02 am

InvestorNewsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Announces the I-GO(TM), a Fully EU Homologated Vehicle

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, today announced that it has secured exclusive sales, distribution and branding rights to the new compact urban delivery electric vehicle, the I-GO, which is fully EU Standard homologated and certified for sale in select European markets. The I-GO bridges the gap between the growing demand for quick deliveries and space constraints found throughout the dense…

Monday Oct 24, 2022 - 9:51 am

InvestorNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Enters into Acquisition Agreement with German-Based Pharmaceutical, Medical Cannabis Distributor

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has inked a definitive agreement with Franchise Global Health Inc. (TSX.V: FGH), a multinational operator in the medical cannabis and pharmaceutical industry. The agreement outlines Flora Growth’s plans to acquire 100% of Franchise Global Health, which has principal operations in Germany, in an all-stock transaction. According to the agreement, the…

Friday Oct 21, 2022 - 3:17 pm

InvestorNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Holds Potential to Represent Multiple Commercial Opportunities

Lexaria Bioscience Corp. (NASDAQ: LEXX), a drug delivery platform innovator, last year announced a review of its successful 2021 antiviral drug program. “Lexaria specifically probed the bioavailability of five DehydraTECH(TM)-processed antiviral drugs for SARS-CoV-2, HIV/AIDS and other infectious diseases from three drug classes, evidencing significant gains with up to a three-fold increase in oral drug delivery into the bloodstream. The demonstrated improvements in absorption, Lexaria…

InvestorNewsBreaks

NewsBreak Category: Tiny Gems

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions